Table 1. Demographic and clinical characteristics of the patients.
| Controls(n = 40) | AS patients(n = 112) | P value | |
| Clinical characteristics | |||
| Age, (years) | 53.3±10.8 | 53.3±10.5 | 0.988 |
| Male, n (%) | 23 (57.5%) | 58 (51.8%) | 0.507 |
| SBP, (mmHg) | 118.4±16.9 | 116.3±15.2 | 0.460 |
| DBP, (mmHg) | 70.7±10.5 | 70.4±9.7 | 0.848 |
| HR, (bpm) | 76.8±10.4 | 80.8±13.6 | 0.086 |
| LVEF, (%) | 60.3±5.6 | 62.3±10.9 | 0.284 |
| LV mass index, (g/m2) | 67.4±10.5 | 106.3±27.5 | <0.001 |
| Etiology | |||
| Degenerative aortic valve diseases | / | 46(41.1%) | / |
| Rheumatic valve diseases | / | 53(47.3%) | / |
| Congenital bicuspid aortic vlave | / | 13(11.6%) | / |
| Medication | |||
| ACEI/ARBs, n (%) | / | 28 (25.0%) | / |
| β-Blockers, n (%) | / | 19 (17.0%) | / |
| Calcium antagonists, n (%) | / | 7 (6.2%) | / |
| Diuretics, n (%) | / | 47 (42.0%) | / |
SBP: systolic blood pressure; DBP: diastolic blood pressure; HR: heart rate; LVEF: left ventricular ejection fraction; ACEI: angiotensin converting enzyme inhibitor; ARB: angiotensin receptor blocker.